Bill

Bill > S1322


NJ S1322

Prohibits sale of certain products using advertisements alluding to controlled dangerous substances or analogs.


summary

Introduced
02/01/2018
In Committee
02/01/2018
Crossed Over
Passed
Dead
01/08/2020

Introduced Session

2018-2019 Regular Session

Bill Summary

This bill prohibits the sale of certain items which use advertisements linked or alluding to controlled dangerous substances or analogs. The bill bans the sale of any food, beverage, or other product meant to be ingested or inhaled which uses the advertisement on its packaging or elsewhere. The bill further prohibits the sale of any product using the advertising, regardless of the product's intended use, to a person under 18 years of age. The bill specifies that the provisions do not apply to any prescription medication dispensed by a pharmacist pursuant to a valid prescription. A violation under the bill would be an unlawful practice under the consumer fraud act, which is punishable by a monetary penalty of not more than $10,000 for a first offense and not more than $20,000 for any subsequent offense. Additionally, a violation can result in a cease and desist order issued by the Attorney General, the assessment of punitive damages, and the awarding of treble damages and costs to the injured.

AI Summary

This bill prohibits the sale of certain products, such as food, beverages, or other ingestible or inhalable items, that use advertisements linked or alluding to controlled dangerous substances or their analogs. The bill also bans the sale of any product using such advertising to a person under 18 years of age. However, the provisions do not apply to prescription medications dispensed by a pharmacist. Violations of this bill would be considered unlawful practices under the consumer fraud act, punishable by monetary penalties, cease and desist orders, and the potential for treble damages and costs.

Committee Categories

Business and Industry

Sponsors (1)

Last Action

Introduced in the Senate, Referred to Senate Commerce Committee (on 02/01/2018)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...